FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Follea De Novo for Minoxidil Response Test

Follea says it has submitted to FDA a de novo application for its Minoxidil Response Test.

Human Drugs

Trump Mentions FDA Role in Opioid Emergency Declaration

President Trump declares the opioid abuse crisis in the U.S. to be a public health emergency while briefly mentioning FDAs role in the effort.

Human Drugs

Genentech sBLA for Avastin in Ovarian Cancer

FDA accepts for review a Genentech supplemental BLA for Avastin (bevacizumab) for its use in combination with chemotherapy, followed by Avastin alone,...

Federal Register

Draft Guide on Breakthrough Device Program

Federal Register notice: FDA makes available a draft guidance entitled Breakthrough Devices Program; Draft Guidance for Industry and Food and Drug Adm...

Human Drugs

FDA Warns Trailer Park Drug Maker

FDAs Los Angeles District issues a nine-page Warning Letter to an OTC drug manufacturer that allegedly makes topical pain drugs in the kitchen of a ho...

Human Drugs

Bill Would Require HHS Drug Price Negotiations

Four congressional Democrats introduce a bill to require HHS to negotiate prices for Medicare Part D covered drugs.

Human Drugs

Drug-Drug Interaction Guidances Out

FDA issues two draft guidances on a systematic, risk-based approach to evaluating drug-drug interactions.

Federal Register

2 Draft Guidances on Drug-Drug Interactions

Federal Register notice: FDA makes available two draft guidances entitled In Vitro Metabolism- and Transporter-Mediated Drug-Drug Interaction Studies ...

Human Drugs

FDA Approves sBLA for Soliris Expanded Use

FDA approves an Alexion Pharmaceuticals supplemental BLA for Soliris (eculizumab) as a treatment for adult patients with generalized myasthenia gravis...

Human Drugs

FDA Boosting Real-World Data in Cancer Trials

FDA Oncology Center of Excellence staff outlines steps to promote greater use of real-world evidence in cancer trials.